SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1now'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DTL_A_BEPA206_1 (CARDIAC TROPONIN C)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 8	PRO A 58 GLU A 511 ARG A 533 MET A 536	None	1.18A	1dtlA-1nowA: undetectable	1dtlA-1nowA: 15.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E7B_A_HLTA4003_1 (SERUM ALBUMIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 9	ILE A 205 VAL A 509 GLY A 510 ALA A 486 LEU A 451	None	0.96A	1e7bA-1nowA: undetectable	1e7bA-1nowA: 20.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HK2_A_T44A3004_1 (SERUM ALBUMIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 7	ALA A 97 GLU A 96 LEU A 93 VAL A 165	None	0.93A	1hk2A-1nowA: undetectable	1hk2A-1nowA: 20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1JFF_B_TA1B601_1 (TUBULIN BETA CHAIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 12	VAL A 239 ASP A 240 PHE A 337 THR A 329 GLY A 293	None IFG A 557 ( 4.7A) None None None	1.16A	1jffB-1nowA: undetectable	1jffB-1nowA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RU9_H_ACTH611_0 (IMMUNOGLOBULIN IGG2A, HEAVY CHAIN IMMUNOGLOBULIN IGG2A, LIGHT CHAIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 6	LEU A 305 TRP A 298 LEU A 254 PHE A 336	None	1.37A	1ru9H-1nowA: undetectable 1ru9L-1nowA: undetectable	1ru9H-1nowA: 17.95 1ru9L-1nowA: 18.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RUK_L_ACTL611_0 (IMMUNOGLOBULIN IGG2A, HEAVY CHAIN IMMUNOGLOBULIN IGG2A, LIGHT CHAIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 6	LEU A 305 TRP A 298 LEU A 254 PHE A 336	None	1.35A	1rukH-1nowA: undetectable 1rukL-1nowA: undetectable	1rukH-1nowA: 17.95 1rukL-1nowA: 18.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HXF_B_TA1B601_1 (TUBULIN BETA CHAIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 12	VAL A 239 ASP A 240 PHE A 337 THR A 329 GLY A 293	None IFG A 557 ( 4.7A) None None None	1.16A	2hxfB-1nowA: undetectable	2hxfB-1nowA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HXH_B_TA1B601_1 (TUBULIN BETA CHAIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 12	VAL A 239 ASP A 240 PHE A 337 THR A 329 GLY A 293	None IFG A 557 ( 4.7A) None None None	1.16A	2hxhB-1nowA: undetectable	2hxhB-1nowA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2LH8_A_VIBA1_1 (MAJOR PRION PROTEIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 6	PRO A 215 HIS A 212 ASP A 240 TYR A 213	None None IFG A 557 ( 4.7A) None	1.38A	2lh8A-1nowA: 0.0	2lh8A-1nowA: 11.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2P4N_B_TA1B601_1 (TUBULIN BETA CHAIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 12	VAL A 239 ASP A 240 PHE A 337 THR A 329 GLY A 293	None IFG A 557 ( 4.7A) None None None	1.16A	2p4nB-1nowA: undetectable	2p4nB-1nowA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_B_ASDB1224_1 (GLUTATHIONE S-TRANSFERASE A3)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 6	PHE A 98 ALA A 168 LEU A 169 ALA A 97	None	0.89A	2vcvB-1nowA: 0.0	2vcvB-1nowA: 17.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_K_ASDK1224_1 (GLUTATHIONE S-TRANSFERASE A3)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 6	PHE A 98 ALA A 168 LEU A 169 ALA A 97	None	0.89A	2vcvK-1nowA: undetectable	2vcvK-1nowA: 17.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WBE_B_TA1B1439_1 (TUBULIN BETA-2B CHAIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 12	VAL A 239 ASP A 240 PHE A 337 THR A 329 GLY A 293	None IFG A 557 ( 4.7A) None None None	1.16A	2wbeB-1nowA: undetectable	2wbeB-1nowA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZIA_B_CL9B401_2 (DEOXYCYTIDINE KINASE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 4	ARG A 528 ASP A 527 LEU A 546 ARG A 512	None None GOL A 559 (-4.5A) None	1.38A	2ziaB-1nowA: 0.0	2ziaB-1nowA: 20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A6J_A_CRNA303_1 (CREATININE AMIDOHYDROLASE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 8	GLU A 288 HIS A 350 HIS A 235 GLU A 422	None	0.93A	3a6jA-1nowA: undetectable	3a6jA-1nowA: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A6J_B_CRNB304_1 (CREATININE AMIDOHYDROLASE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 7	GLU A 288 HIS A 350 HIS A 235 GLU A 422	None	0.94A	3a6jB-1nowA: undetectable	3a6jB-1nowA: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A6J_C_CRNC305_1 (CREATININE AMIDOHYDROLASE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 8	GLU A 288 HIS A 350 HIS A 235 GLU A 422	None	0.93A	3a6jC-1nowA: undetectable	3a6jC-1nowA: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A6J_E_CRNE306_1 (CREATININE AMIDOHYDROLASE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 8	GLU A 288 HIS A 350 HIS A 235 GLU A 422	None	0.96A	3a6jE-1nowA: undetectable	3a6jE-1nowA: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A6J_F_CRNF307_1 (CREATININE AMIDOHYDROLASE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 8	GLU A 288 HIS A 350 HIS A 235 GLU A 422	None	0.92A	3a6jF-1nowA: undetectable	3a6jF-1nowA: 20.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AOD_C_RFPC2002_1 (ACRIFLAVINE RESISTANCE PROTEIN B)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 12	ALA A 227 PHE A 98 GLY A 167 ARG A 170 LEU A 93	None	1.33A	3aodC-1nowA: 0.0	3aodC-1nowA: 19.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3C0Z_A_SHHA301_1 (HISTONE DEACETYLASE 7A)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 5	HIS A 237 ASP A 290 HIS A 294 ASP A 354	None None IFG A 557 ( 4.3A) IFG A 557 (-3.6A)	1.19A	3c0zA-1nowA: 2.3	3c0zA-1nowA: 21.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DCO_B_TA1B601_1 (BOVINE BETA TUBULIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 12	VAL A 239 ASP A 240 PHE A 337 THR A 329 GLY A 293	None IFG A 557 ( 4.7A) None None None	1.16A	3dcoB-1nowA: undetectable	3dcoB-1nowA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EDL_B_TA1B601_1 (BETA TUBULIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 12	VAL A 239 ASP A 240 PHE A 337 THR A 329 GLY A 293	None IFG A 557 ( 4.7A) None None None	1.15A	3edlB-1nowA: undetectable	3edlB-1nowA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FI0_P_TRPP1001_0 (TRYPTOPHANYL-TRNA SYNTHETASE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 7	GLY A 171 ASP A 196 ILE A 194 GLN A 177	None	0.87A	3fi0P-1nowA: undetectable	3fi0P-1nowA: 19.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HII_A_PNTA901_0 (AMILORIDE-SENSITIVE AMINE OXIDASE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 12	ASP A 354 TYR A 450 ASP A 452 TRP A 489 GLY A 490	IFG A 557 (-3.6A) IFG A 557 (-4.6A) IFG A 557 (-3.2A) IFG A 557 (-3.6A) None	1.38A	3hiiA-1nowA: undetectable	3hiiA-1nowA: 20.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IZ0_B_TA1B820_1 (BETA TUBULIN, CHAIN B FROM PDB 1JFF)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 12	VAL A 239 ASP A 240 PHE A 337 THR A 329 GLY A 293	None IFG A 557 ( 4.7A) None None None	1.15A	3iz0B-1nowA: undetectable	3iz0B-1nowA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KP6_B_SALB3001_1 (TRANSCRIPTIONAL REGULATOR TCAR)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 8	GLU A 173 ASN A 229 HIS A 532 MET A 536	None	0.91A	3kp6A-1nowA: 0.0 3kp6B-1nowA: 0.0	3kp6A-1nowA: 13.61 3kp6B-1nowA: 13.61
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LMY_A_CP6A562_1 (BETA-HEXOSAMINIDASE SUBUNIT BETA)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	12 / 12	ARG A 211 HIS A 237 ASP A 240 ASP A 290 HIS A 294 ASP A 354 TRP A 424 TYR A 450 ASP A 452 LEU A 453 TRP A 489 GLU A 491	IFG A 557 (-2.8A) None IFG A 557 ( 4.7A) None IFG A 557 ( 4.3A) IFG A 557 (-3.6A) IFG A 557 (-3.6A) IFG A 557 (-4.6A) IFG A 557 (-3.2A) None IFG A 557 (-3.6A) IFG A 557 (-3.2A)	0.32A	3lmyA-1nowA: 62.9	3lmyA-1nowA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LMY_B_CP6B563_1 (BETA-HEXOSAMINIDASE SUBUNIT BETA)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	12 / 12	ARG A 211 HIS A 237 ASP A 240 ASP A 290 HIS A 294 ASP A 354 GLU A 355 TRP A 405 TRP A 424 TYR A 450 TRP A 489 GLU A 491	IFG A 557 (-2.8A) None IFG A 557 ( 4.7A) None IFG A 557 ( 4.3A) IFG A 557 (-3.6A) IFG A 557 (-3.1A) IFG A 557 (-3.3A) IFG A 557 (-3.6A) IFG A 557 (-4.6A) IFG A 557 (-3.6A) IFG A 557 (-3.2A)	0.34A	3lmyB-1nowA: 62.6	3lmyB-1nowA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LMY_B_CP6B563_1 (BETA-HEXOSAMINIDASE SUBUNIT BETA)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 12	HIS A 237 ASP A 240 GLU A 491 TYR A 450 TRP A 489	None IFG A 557 ( 4.7A) IFG A 557 (-3.2A) IFG A 557 (-4.6A) IFG A 557 (-3.6A)	1.39A	3lmyB-1nowA: 62.6	3lmyB-1nowA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NBQ_B_URFB400_1 (URIDINE PHOSPHORYLASE 1)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 8	GLY A 299 LEU A 305 LEU A 306 ILE A 322	None	0.90A	3nbqB-1nowA: 0.9	3nbqB-1nowA: 21.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NBQ_C_URFC400_1 (URIDINE PHOSPHORYLASE 1)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 8	GLY A 299 LEU A 305 LEU A 306 ILE A 322	None	0.83A	3nbqC-1nowA: 1.2	3nbqC-1nowA: 21.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDI_A_SAMA601_0 (METHYLTRANSFERASE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 12	PHE A 386 ILE A 367 PHE A 380 PHE A 376 THR A 325	None	1.33A	3ndiA-1nowA: undetectable	3ndiA-1nowA: 21.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3R55_A_PZAA598_0 (LACTOPEROXIDASE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	3 / 3	GLU A 362 PHE A 380 GLN A 368	None	1.01A	3r55A-1nowA: undetectable	3r55A-1nowA: 20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SMT_A_ACTA1001_0 (HISTONE-LYSINE N-METHYLTRANSFERASE SETD3)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 5	LEU A 469 PHE A 481 PHE A 200 ARG A 199	None	1.15A	3smtA-1nowA: undetectable	3smtA-1nowA: 22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VRJ_A_1KXA301_1 (HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN 10-MER PEPTIDE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 12	ILE A 275 VAL A 271 TYR A 266 ILE A 340 THR A 209	None	1.18A	3vrjA-1nowA: undetectable 3vrjC-1nowA: undetectable	3vrjA-1nowA: 21.03 3vrjC-1nowA: 4.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VYW_C_SAMC401_1 (MNMC2)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 6	GLY A 352 GLU A 288 ASP A 208 GLU A 491	None None None IFG A 557 (-3.2A)	1.06A	3vywC-1nowA: undetectable	3vywC-1nowA: 23.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DF3_A_SAMA301_1 (FIBRILLARIN-LIKE RRNA/TRNA 2'-O-METHYLTRANSFERA SE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	3 / 3	TYR A 149 THR A 174 GLU A 147	None	0.68A	4df3A-1nowA: 0.8	4df3A-1nowA: 17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DF3_B_SAMB301_1 (FIBRILLARIN-LIKE RRNA/TRNA 2'-O-METHYLTRANSFERA SE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	3 / 3	TYR A 149 THR A 174 GLU A 147	None	0.68A	4df3B-1nowA: 0.8	4df3B-1nowA: 17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K17_B_OHBB701_0 (LEUCINE-RICH REPEAT-CONTAINING PROTEIN 16A)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 5	GLU A 147 SER A 148 PRO A 198 SER A 197	None GOL A 558 (-3.1A) None None	1.20A	4k17B-1nowA: 0.0	4k17B-1nowA: 20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NTX_A_AMRA509_1 (ACID-SENSING ION CHANNEL 1 BASIC PHOSPHOLIPASE A2 HOMOLOG TX-BETA)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 6	GLU A 357 ASP A 354 ASP A 290 ARG A 211	None IFG A 557 (-3.6A) None IFG A 557 (-2.8A)	1.15A	4ntxA-1nowA: 0.0 4ntxC-1nowA: undetectable	4ntxA-1nowA: 21.20 4ntxC-1nowA: 11.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PEV_C_ADNC501_2 (MEMBRANE LIPOPROTEIN FAMILY PROTEIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	3 / 3	PRO A 500 VAL A 493 HIS A 212	None	0.71A	4pevC-1nowA: undetectable	4pevC-1nowA: 22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RJD_B_TFPB204_1 (CALMODULIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 8	LEU A 351 GLY A 352 GLU A 288 GLU A 485 GLU A 422	None	1.32A	4rjdA-1nowA: undetectable 4rjdB-1nowA: undetectable	4rjdA-1nowA: 7.23 4rjdB-1nowA: 7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XR4_B_AG2B511_1 (HOMOSPERMIDINE SYNTHASE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	3 / 3	VAL A 443 PHE A 409 ARG A 435	None	0.84A	4xr4B-1nowA: undetectable	4xr4B-1nowA: 21.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZME_B_ADNB902_1 (MYOSIN HEAVY CHAIN KINASE A)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 10	VAL A 165 LEU A 160 LEU A 169 LEU A 172 PHE A 98	None	1.24A	4zmeB-1nowA: undetectable	4zmeB-1nowA: 20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HIE_B_P06B801_2 (SERINE/THREONINE-PRO TEIN KINASE B-RAF)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 7	ILE A 205 GLY A 204 LEU A 93 PHE A 140	None	0.90A	5hieB-1nowA: undetectable	5hieB-1nowA: 20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IGY_A_ERYA403_1 (MACROLIDE 2'-PHOSPHOTRANSFERAS E II)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 6	TYR A 101 ILE A 283 ARG A 281 TYR A 277	None	1.42A	5igyA-1nowA: undetectable	5igyA-1nowA: 21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IWU_A_ACTA402_0 (MACROLIDE 2'-PHOSPHOTRANSFERAS E II)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 6	PHE A 337 VAL A 391 TYR A 387 ILE A 322	None	1.27A	5iwuA-1nowA: 0.0	5iwuA-1nowA: 21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N9X_A_THRA601_0 (ADENYLATION DOMAIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 7	PHE A 187 GLY A 107 GLY A 103 HIS A 102	None	0.90A	5n9xA-1nowA: undetectable	5n9xA-1nowA: 23.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NUM_A_Z80A201_1 (BETA-LACTOGLOBULIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 8	ILE A 349 LEU A 351 ILE A 395 ILE A 398	None	0.69A	5numA-1nowA: undetectable	5numA-1nowA: 9.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OGC_B_TA1B601_1 (TUBULIN BETA CHAIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 12	VAL A 239 ASP A 240 PHE A 337 THR A 329 GLY A 293	None IFG A 557 ( 4.7A) None None None	1.14A	5ogcB-1nowA: 2.1	5ogcB-1nowA: 21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UMW_B_RBFB201_1 (GLYOXALASE/BLEOMYCIN RESISANCE PROTEIN/DIOXYGENASE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 7	ARG A 279 GLU A 276 LEU A 169 ARG A 100	None	0.93A	5umwB-1nowA: 0.0 5umwE-1nowA: 0.0	5umwB-1nowA: 10.24 5umwE-1nowA: 10.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WYQ_A_SAMA401_1 (TRNA (GUANINE-N(1)-)-METH YLTRANSFERASE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 4	ASP A 208 SER A 210 ASP A 240 HIS A 294	None None IFG A 557 ( 4.7A) IFG A 557 ( 4.3A)	1.36A	5wyqB-1nowA: 0.3	5wyqB-1nowA: 18.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6D8P_B_ACTB804_0 (UNCHARACTERIZED PROTEIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 4	HIS A 81 VAL A 165 LEU A 94 ALA A 87	None	1.42A	6d8pB-1nowA: 2.6	6d8pB-1nowA: 19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FGD_A_ACTA807_0 (GEPHYRIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 4	PRO A 468 LEU A 445 VAL A 509 ARG A 512	None	1.40A	6fgdA-1nowA: 1.2	6fgdA-1nowA: 22.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MN1_A_LLLA302_0 (AMINOGLYCOSIDE N(3)-ACETYLTRANSFERA SE)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	5 / 10	ASP A 354 TRP A 405 GLY A 353 ASP A 317 THR A 295	IFG A 557 (-3.6A) IFG A 557 (-3.3A) None None None	1.33A	6mn1A-1nowA: 0.0	6mn1A-1nowA: 10.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6MN8_A_GLYA607_0 (UNCHARACTERIZED PROTEIN)	1now	BETA-HEXOSAMINIDASE BETA CHAIN (Homo sapiens)	4 / 4	GLU A 288 ASP A 208 ARG A 211 TRP A 489	None None IFG A 557 (-2.8A) IFG A 557 (-3.6A)	1.14A	6mn8A-1nowA: 0.0	6mn8A-1nowA: 20.70

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1DTL_A_BEPA206_1","CARDIAC TROPONIN C","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"PRO A  58;GLU A 511;ARG A 533;MET A 536","None","1.18A","1dtlA-1nowA:undetectable","1dtlA-1nowA:15.13"],["1E7B_A_HLTA4003_1","SERUM ALBUMIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"ILE A 205;VAL A 509;GLY A 510;ALA A 486;LEU A 451","None","0.96A","1e7bA-1nowA:undetectable","1e7bA-1nowA:20.54"],["1HK2_A_T44A3004_1","SERUM ALBUMIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"ALA A  97;GLU A  96;LEU A  93;VAL A 165","None","0.93A","1hk2A-1nowA:undetectable","1hk2A-1nowA:20.98"],["1JFF_B_TA1B601_1","TUBULIN BETA CHAIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"VAL A 239;ASP A 240;PHE A 337;THR A 329;GLY A 293","None;IFG A 557 ( 4.7A);None;None;None","1.16A","1jffB-1nowA:undetectable","1jffB-1nowA:21.64"],["1RU9_H_ACTH611_0","IMMUNOGLOBULIN IGG2A, HEAVY CHAIN;IMMUNOGLOBULIN IGG2A, LIGHT CHAIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"LEU A 305;TRP A 298;LEU A 254;PHE A 336","None","1.37A","1ru9H-1nowA:undetectable;1ru9L-1nowA:undetectable","1ru9H-1nowA:17.95;1ru9L-1nowA:18.28"],["1RUK_L_ACTL611_0","IMMUNOGLOBULIN IGG2A, HEAVY CHAIN;IMMUNOGLOBULIN IGG2A, LIGHT CHAIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"LEU A 305;TRP A 298;LEU A 254;PHE A 336","None","1.35A","1rukH-1nowA:undetectable;1rukL-1nowA:undetectable","1rukH-1nowA:17.95;1rukL-1nowA:18.28"],["2HXF_B_TA1B601_1","TUBULIN BETA CHAIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"VAL A 239;ASP A 240;PHE A 337;THR A 329;GLY A 293","None;IFG A 557 ( 4.7A);None;None;None","1.16A","2hxfB-1nowA:undetectable","2hxfB-1nowA:21.64"],["2HXH_B_TA1B601_1","TUBULIN BETA CHAIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"VAL A 239;ASP A 240;PHE A 337;THR A 329;GLY A 293","None;IFG A 557 ( 4.7A);None;None;None","1.16A","2hxhB-1nowA:undetectable","2hxhB-1nowA:21.64"],["2LH8_A_VIBA1_1","MAJOR PRION PROTEIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"PRO A 215;HIS A 212;ASP A 240;TYR A 213","None;None;IFG A 557 ( 4.7A);None","1.38A","2lh8A-1nowA:0.0","2lh8A-1nowA:11.45"],["2P4N_B_TA1B601_1","TUBULIN BETA CHAIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"VAL A 239;ASP A 240;PHE A 337;THR A 329;GLY A 293","None;IFG A 557 ( 4.7A);None;None;None","1.16A","2p4nB-1nowA:undetectable","2p4nB-1nowA:21.64"],["2VCV_B_ASDB1224_1","GLUTATHIONE S-TRANSFERASE A3","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"PHE A  98;ALA A 168;LEU A 169;ALA A  97","None","0.89A","2vcvB-1nowA:0.0","2vcvB-1nowA:17.91"],["2VCV_K_ASDK1224_1","GLUTATHIONE S-TRANSFERASE A3","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"PHE A  98;ALA A 168;LEU A 169;ALA A  97","None","0.89A","2vcvK-1nowA:undetectable","2vcvK-1nowA:17.91"],["2WBE_B_TA1B1439_1","TUBULIN BETA-2B CHAIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"VAL A 239;ASP A 240;PHE A 337;THR A 329;GLY A 293","None;IFG A 557 ( 4.7A);None;None;None","1.16A","2wbeB-1nowA:undetectable","2wbeB-1nowA:21.64"],["2ZIA_B_CL9B401_2","DEOXYCYTIDINE KINASE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"ARG A 528;ASP A 527;LEU A 546;ARG A 512","None;None;GOL A 559 (-4.5A);None","1.38A","2ziaB-1nowA:0.0","2ziaB-1nowA:20.47"],["3A6J_A_CRNA303_1","CREATININE AMIDOHYDROLASE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"GLU A 288;HIS A 350;HIS A 235;GLU A 422","None","0.93A","3a6jA-1nowA:undetectable","3a6jA-1nowA:20.24"],["3A6J_B_CRNB304_1","CREATININE AMIDOHYDROLASE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"GLU A 288;HIS A 350;HIS A 235;GLU A 422","None","0.94A","3a6jB-1nowA:undetectable","3a6jB-1nowA:20.24"],["3A6J_C_CRNC305_1","CREATININE AMIDOHYDROLASE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"GLU A 288;HIS A 350;HIS A 235;GLU A 422","None","0.93A","3a6jC-1nowA:undetectable","3a6jC-1nowA:20.24"],["3A6J_E_CRNE306_1","CREATININE AMIDOHYDROLASE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"GLU A 288;HIS A 350;HIS A 235;GLU A 422","None","0.96A","3a6jE-1nowA:undetectable","3a6jE-1nowA:20.24"],["3A6J_F_CRNF307_1","CREATININE AMIDOHYDROLASE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"GLU A 288;HIS A 350;HIS A 235;GLU A 422","None","0.92A","3a6jF-1nowA:undetectable","3a6jF-1nowA:20.24"],["3AOD_C_RFPC2002_1","ACRIFLAVINE RESISTANCE PROTEIN B","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"ALA A 227;PHE A  98;GLY A 167;ARG A 170;LEU A  93","None","1.33A","3aodC-1nowA:0.0","3aodC-1nowA:19.11"],["3C0Z_A_SHHA301_1","HISTONE DEACETYLASE 7A","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"HIS A 237;ASP A 290;HIS A 294;ASP A 354","None;None;IFG A 557 ( 4.3A);IFG A 557 (-3.6A)","1.19A","3c0zA-1nowA:2.3","3c0zA-1nowA:21.05"],["3DCO_B_TA1B601_1","BOVINE BETA TUBULIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"VAL A 239;ASP A 240;PHE A 337;THR A 329;GLY A 293","None;IFG A 557 ( 4.7A);None;None;None","1.16A","3dcoB-1nowA:undetectable","3dcoB-1nowA:21.64"],["3EDL_B_TA1B601_1","BETA TUBULIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"VAL A 239;ASP A 240;PHE A 337;THR A 329;GLY A 293","None;IFG A 557 ( 4.7A);None;None;None","1.15A","3edlB-1nowA:undetectable","3edlB-1nowA:21.64"],["3FI0_P_TRPP1001_0","TRYPTOPHANYL-TRNA SYNTHETASE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"GLY A 171;ASP A 196;ILE A 194;GLN A 177","None","0.87A","3fi0P-1nowA:undetectable","3fi0P-1nowA:19.92"],["3HII_A_PNTA901_0","AMILORIDE-SENSITIVE AMINE OXIDASE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"ASP A 354;TYR A 450;ASP A 452;TRP A 489;GLY A 490","IFG A 557 (-3.6A);IFG A 557 (-4.6A);IFG A 557 (-3.2A);IFG A 557 (-3.6A);None","1.38A","3hiiA-1nowA:undetectable","3hiiA-1nowA:20.08"],["3IZ0_B_TA1B820_1","BETA TUBULIN, CHAIN B FROM PDB 1JFF","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"VAL A 239;ASP A 240;PHE A 337;THR A 329;GLY A 293","None;IFG A 557 ( 4.7A);None;None;None","1.15A","3iz0B-1nowA:undetectable","3iz0B-1nowA:21.64"],["3KP6_B_SALB3001_1","TRANSCRIPTIONAL REGULATOR TCAR;TRANSCRIPTIONAL REGULATOR TCAR","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"GLU A 173;ASN A 229;HIS A 532;MET A 536","None","0.91A","3kp6A-1nowA:0.0;3kp6B-1nowA:0.0","3kp6A-1nowA:13.61;3kp6B-1nowA:13.61"],["3LMY_A_CP6A562_1","BETA-HEXOSAMINIDASE SUBUNIT BETA","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",12,"ARG A 211;HIS A 237;ASP A 240;ASP A 290;HIS A 294;ASP A 354;TRP A 424;TYR A 450;ASP A 452;LEU A 453;TRP A 489;GLU A 491","IFG A 557 (-2.8A);None;IFG A 557 ( 4.7A);None;IFG A 557 ( 4.3A);IFG A 557 (-3.6A);IFG A 557 (-3.6A);IFG A 557 (-4.6A);IFG A 557 (-3.2A);None;IFG A 557 (-3.6A);IFG A 557 (-3.2A)","0.32A","3lmyA-1nowA:62.9","3lmyA-1nowA:100.00"],["3LMY_B_CP6B563_1","BETA-HEXOSAMINIDASE SUBUNIT BETA","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",12,"ARG A 211;HIS A 237;ASP A 240;ASP A 290;HIS A 294;ASP A 354;GLU A 355;TRP A 405;TRP A 424;TYR A 450;TRP A 489;GLU A 491","IFG A 557 (-2.8A);None;IFG A 557 ( 4.7A);None;IFG A 557 ( 4.3A);IFG A 557 (-3.6A);IFG A 557 (-3.1A);IFG A 557 (-3.3A);IFG A 557 (-3.6A);IFG A 557 (-4.6A);IFG A 557 (-3.6A);IFG A 557 (-3.2A)","0.34A","3lmyB-1nowA:62.6","3lmyB-1nowA:100.00"],["3LMY_B_CP6B563_1","BETA-HEXOSAMINIDASE SUBUNIT BETA","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"HIS A 237;ASP A 240;GLU A 491;TYR A 450;TRP A 489","None;IFG A 557 ( 4.7A);IFG A 557 (-3.2A);IFG A 557 (-4.6A);IFG A 557 (-3.6A)","1.39A","3lmyB-1nowA:62.6","3lmyB-1nowA:100.00"],["3NBQ_B_URFB400_1","URIDINE PHOSPHORYLASE 1","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"GLY A 299;LEU A 305;LEU A 306;ILE A 322","None","0.90A","3nbqB-1nowA:0.9","3nbqB-1nowA:21.47"],["3NBQ_C_URFC400_1","URIDINE PHOSPHORYLASE 1","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"GLY A 299;LEU A 305;LEU A 306;ILE A 322","None","0.83A","3nbqC-1nowA:1.2","3nbqC-1nowA:21.47"],["3NDI_A_SAMA601_0","METHYLTRANSFERASE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"PHE A 386;ILE A 367;PHE A 380;PHE A 376;THR A 325","None","1.33A","3ndiA-1nowA:undetectable","3ndiA-1nowA:21.66"],["3R55_A_PZAA598_0","LACTOPEROXIDASE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",3,"GLU A 362;PHE A 380;GLN A 368","None","1.01A","3r55A-1nowA:undetectable","3r55A-1nowA:20.13"],["3SMT_A_ACTA1001_0","HISTONE-LYSINE N-METHYLTRANSFERASE SETD3","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"LEU A 469;PHE A 481;PHE A 200;ARG A 199","None","1.15A","3smtA-1nowA:undetectable","3smtA-1nowA:22.44"],["3VRJ_A_1KXA301_1","HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, B-57 ALPHA CHAIN;10-MER PEPTIDE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"ILE A 275;VAL A 271;TYR A 266;ILE A 340;THR A 209","None","1.18A","3vrjA-1nowA:undetectable;3vrjC-1nowA:undetectable","3vrjA-1nowA:21.03;3vrjC-1nowA:4.02"],["3VYW_C_SAMC401_1","MNMC2","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"GLY A 352;GLU A 288;ASP A 208;GLU A 491","None;None;None;IFG A 557 (-3.2A)","1.06A","3vywC-1nowA:undetectable","3vywC-1nowA:23.30"],["4DF3_A_SAMA301_1","FIBRILLARIN-LIKE RRNA\/TRNA 2'-O-METHYLTRANSFERASE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",3,"TYR A 149;THR A 174;GLU A 147","None","0.68A","4df3A-1nowA:0.8","4df3A-1nowA:17.22"],["4DF3_B_SAMB301_1","FIBRILLARIN-LIKE RRNA\/TRNA 2'-O-METHYLTRANSFERASE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",3,"TYR A 149;THR A 174;GLU A 147","None","0.68A","4df3B-1nowA:0.8","4df3B-1nowA:17.22"],["4K17_B_OHBB701_0","LEUCINE-RICH REPEAT-CONTAINING PROTEIN 16A","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"GLU A 147;SER A 148;PRO A 198;SER A 197","None;GOL A 558 (-3.1A);None;None","1.20A","4k17B-1nowA:0.0","4k17B-1nowA:20.18"],["4NTX_A_AMRA509_1","ACID-SENSING ION CHANNEL 1;BASIC PHOSPHOLIPASE A2 HOMOLOG TX-BETA","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"GLU A 357;ASP A 354;ASP A 290;ARG A 211","None;IFG A 557 (-3.6A);None;IFG A 557 (-2.8A)","1.15A","4ntxA-1nowA:0.0;4ntxC-1nowA:undetectable","4ntxA-1nowA:21.20;4ntxC-1nowA:11.72"],["4PEV_C_ADNC501_2","MEMBRANE LIPOPROTEIN FAMILY PROTEIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",3,"PRO A 500;VAL A 493;HIS A 212","None","0.71A","4pevC-1nowA:undetectable","4pevC-1nowA:22.10"],["4RJD_B_TFPB204_1","CALMODULIN;CALMODULIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"LEU A 351;GLY A 352;GLU A 288;GLU A 485;GLU A 422","None","1.32A","4rjdA-1nowA:undetectable;4rjdB-1nowA:undetectable","4rjdA-1nowA:7.23;4rjdB-1nowA:7.23"],["4XR4_B_AG2B511_1","HOMOSPERMIDINE SYNTHASE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",3,"VAL A 443;PHE A 409;ARG A 435","None","0.84A","4xr4B-1nowA:undetectable","4xr4B-1nowA:21.63"],["4ZME_B_ADNB902_1","MYOSIN HEAVY CHAIN KINASE A","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"VAL A 165;LEU A 160;LEU A 169;LEU A 172;PHE A  98","None","1.24A","4zmeB-1nowA:undetectable","4zmeB-1nowA:20.96"],["5HIE_B_P06B801_2","SERINE\/THREONINE-PROTEIN KINASE B-RAF","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"ILE A 205;GLY A 204;LEU A  93;PHE A 140","None","0.90A","5hieB-1nowA:undetectable","5hieB-1nowA:20.12"],["5IGY_A_ERYA403_1","MACROLIDE 2'-PHOSPHOTRANSFERASE II","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"TYR A 101;ILE A 283;ARG A 281;TYR A 277","None","1.42A","5igyA-1nowA:undetectable","5igyA-1nowA:21.57"],["5IWU_A_ACTA402_0","MACROLIDE 2'-PHOSPHOTRANSFERASE II","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"PHE A 337;VAL A 391;TYR A 387;ILE A 322","None","1.27A","5iwuA-1nowA:0.0","5iwuA-1nowA:21.57"],["5N9X_A_THRA601_0","ADENYLATION DOMAIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"PHE A 187;GLY A 107;GLY A 103;HIS A 102","None","0.90A","5n9xA-1nowA:undetectable","5n9xA-1nowA:23.15"],["5NUM_A_Z80A201_1","BETA-LACTOGLOBULIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"ILE A 349;LEU A 351;ILE A 395;ILE A 398","None","0.69A","5numA-1nowA:undetectable","5numA-1nowA:9.51"],["5OGC_B_TA1B601_1","TUBULIN BETA CHAIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"VAL A 239;ASP A 240;PHE A 337;THR A 329;GLY A 293","None;IFG A 557 ( 4.7A);None;None;None","1.14A","5ogcB-1nowA:2.1","5ogcB-1nowA:21.64"],["5UMW_B_RBFB201_1","GLYOXALASE\/BLEOMYCIN RESISANCE PROTEIN\/DIOXYGENASE;GLYOXALASE\/BLEOMYCIN RESISANCE PROTEIN\/DIOXYGENASE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"ARG A 279;GLU A 276;LEU A 169;ARG A 100","None","0.93A","5umwB-1nowA:0.0;5umwE-1nowA:0.0","5umwB-1nowA:10.24;5umwE-1nowA:10.24"],["5WYQ_A_SAMA401_1","TRNA (GUANINE-N(1)-)-METHYLTRANSFERASE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"ASP A 208;SER A 210;ASP A 240;HIS A 294","None;None;IFG A 557 ( 4.7A);IFG A 557 ( 4.3A)","1.36A","5wyqB-1nowA:0.3","5wyqB-1nowA:18.97"],["6D8P_B_ACTB804_0","UNCHARACTERIZED PROTEIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"HIS A  81;VAL A 165;LEU A  94;ALA A  87","None","1.42A","6d8pB-1nowA:2.6","6d8pB-1nowA:19.68"],["6FGD_A_ACTA807_0","GEPHYRIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"PRO A 468;LEU A 445;VAL A 509;ARG A 512","None","1.40A","6fgdA-1nowA:1.2","6fgdA-1nowA:22.68"],["6MN1_A_LLLA302_0","AMINOGLYCOSIDE N(3)-ACETYLTRANSFERASE","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",5,"ASP A 354;TRP A 405;GLY A 353;ASP A 317;THR A 295","IFG A 557 (-3.6A);IFG A 557 (-3.3A);None;None;None","1.33A","6mn1A-1nowA:0.0","6mn1A-1nowA:10.59"],["6MN8_A_GLYA607_0","UNCHARACTERIZED PROTEIN","1now","BETA-HEXOSAMINIDASE BETA CHAIN","Homo sapiens",4,"GLU A 288;ASP A 208;ARG A 211;TRP A 489","None;None;IFG A 557 (-2.8A);IFG A 557 (-3.6A)","1.14A","6mn8A-1nowA:0.0","6mn8A-1nowA:20.70"]]